A placebo-controlled clinical trial is conducted to assess whether a new antihypertensive drug is more effective than standard therapy. A total of 5000 patients with essential hypertension are enrolled and randomly assigned to one of two groups: 2500 patients receive the new drug and 2500 patients receive placebo. If the alpha is set at 0.01 instead of 0.05, which of the following is the most likely result?
A) There will be a higher rate of adverse reactions in the group receiving the new drug compared to the placebo group.
B) The new antihypertensive drug will show a statistically significant improvement over standard therapy in reducing blood pressure.
C) The two treatments will show no statistically significant difference in their effectiveness.
D) The placebo group will have a higher rate of blood pressure reduction compared to the group receiving the new drug.